These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29596797)

  • 1. Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin.
    Huang Y; Cao S; Zhang Q; Zhang H; Fan Y; Qiu F; Kang N
    Arch Biochem Biophys; 2018 May; 646():31-37. PubMed ID: 29596797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin analogues and their hybrid molecules as multifunctional drugs.
    Noureddin SA; El-Shishtawy RM; Al-Footy KO
    Eur J Med Chem; 2019 Nov; 182():111631. PubMed ID: 31479974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets.
    Chainoglou E; Hadjipavlou-Litina D
    Expert Opin Drug Discov; 2019 Aug; 14(8):821-842. PubMed ID: 31094233
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
    Teymouri M; Barati N; Pirro M; Sahebkar A
    J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities.
    Yen FL; Wu TH; Tzeng CW; Lin LT; Lin CC
    J Agric Food Chem; 2010 Jun; 58(12):7376-82. PubMed ID: 20486686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives.
    Xu XY; Meng X; Li S; Gan RY; Li Y; Li HB
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30347782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
    Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
    Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin: a boon to colonic diseases.
    Sareen R; Jain N; Pandit V
    Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).
    Zhao C; Liu Z; Liang G
    Curr Pharm Des; 2013; 19(11):2114-35. PubMed ID: 23116317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
    Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
    Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress.
    Martinez-Cifuentes M; Weiss-Lopez B; Santos LS; Araya-Maturana R
    Curr Top Med Chem; 2015; 15(17):1663-72. PubMed ID: 25915614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Interactions of Curcumin Biotransformed Molecules with the N-Terminal Residues of Cytotoxic-Associated Gene A Protein Provide Insights into Suppression of Oncogenic Activities.
    Srivastava AK; Singh D; Roy BK
    Interdiscip Sci; 2017 Mar; 9(1):116-129. PubMed ID: 26798036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as a potential protective compound against cardiac diseases.
    Jiang S; Han J; Li T; Xin Z; Ma Z; Di W; Hu W; Gong B; Di S; Wang D; Yang Y
    Pharmacol Res; 2017 May; 119():373-383. PubMed ID: 28274852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.
    Aggarwal BB; Yuan W; Li S; Gupta SC
    Mol Nutr Food Res; 2013 Sep; 57(9):1529-42. PubMed ID: 23847105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile.
    Momtazi AA; Sahebkar A
    Curr Pharm Des; 2016; 22(28):4386-97. PubMed ID: 27229723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin and Health.
    Pulido-Moran M; Moreno-Fernandez J; Ramirez-Tortosa C; Ramirez-Tortosa M
    Molecules; 2016 Feb; 21(3):264. PubMed ID: 26927041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Studies of New Multifunctional Curcumin Platforms for Anticancer Drug Delivery.
    Bazylevich A; Tuchinsky H; Zigman-Hoffman E; Weissman R; Shpilberg O; Hershkovitz-Rokah O; Patsenker L; Gellerman G
    Med Chem; 2019; 15(5):537-549. PubMed ID: 30501600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
    Bayomi SM; El-Kashef HA; El-Ashmawy MB; Nasr MN; El-Sherbeny MA; Abdel-Aziz NI; El-Sayed MA; Suddek GM; El-Messery SM; Ghaly MA
    Eur J Med Chem; 2015 Aug; 101():584-94. PubMed ID: 26197162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease.
    Patel SS; Acharya A; Ray RS; Agrawal R; Raghuwanshi R; Jain P
    Crit Rev Food Sci Nutr; 2020; 60(6):887-939. PubMed ID: 30632782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcuminoid metabolism and its contribution to the pharmacological effects.
    Wang K; Qiu F
    Curr Drug Metab; 2013 Sep; 14(7):791-806. PubMed ID: 23937173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.